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Purpose: This study investigates the relationship between whole-body bioimpedance
vector displacement, using bioelectrical impedance vector analysis (BIVA), and renal
function through serum biomarkers [creatinine, urea, sodium, C-reactive protein (CRP),
and creatine kinase] and urine biomarkers after a marathon.
Methods: Bioimpedance measurements were taken among 19 non-elite runners at
24 h pre-race, immediately post-race, and at 48 h post-race. The bioimpedance
measurements were analyzed by BIVA using the Hotelling’s T2 test. The runners were
divided according to a cutoff of serum creatinine level immediately post-race in G1
(<1.2 mg/dl of serum creatinine level) and G2 (≥1.2 mg/dl of serum creatinine level).
The increase of the serum creatinine levels in 83% of G2 runners was related to acute
kidney injury (AKI) stage 1.
Results: Neither G1 nor G2 showed a creatinine clearance rate (CCr) lower than
60 ml/min. G2 showed a significant increase in CRP values at 48 h post-race vs
baseline compared to G1 (P < 0.05), with over 5 mg/L (6.8–15.2) in 92% of the runners,
and in CK values with over 215 U/L (282–1,882) at 48 h post-race in 100% of the
runners. By BIVA, the 95% confidence ellipses of G2 showed shorter bioimpedance
vectors than G1, with a noticeable minor Xc/H (P < 0.01), indicating an expansion
on extracellular water and inflammation. The runners with 48 h post-race Xc/H values
≤30.5 , with a decrease from −3 to −12% with respect to the Xc/H value at 24 h
pre-race, indicated AKI stage 1 with 85.7% sensitivity and 91.7% specificity, with a
direct correlation between AKI stage 1 with greater CRP values at 48 h post-race and
bioimpedance vector displacement, but not with CK values at 48 h post-race.
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Conclusion: Through this data collection, it was evidenced that a transient reduction
in renal function is more related to inflammatory factors than muscle damage. The
BIVA method along with serum biomarkers could be used to follow up the kidney
function in runners.
Keywords: marathon race, BIVA, serum creatinine, C-reactive protein, serum creatine kinase, AKI stage 1
INTRODUCTION
The usual practice of sport has a direct positive impact on
physical health in general (Hawley et al., 2014). In marathon
races (42.195 km), non-elite participants increased by 25-fold in
the last 40 years. For example, in the 2017 Barcelona marathon,
there were 19,740 runners, whereas in the 2007 marathon
there were 7,430 runners (Zurich Barcelona Marathon, 2019).
However, marathon running can induce transient changes in
renal filtration function due to neurohormonal, inflammatory,
and oxidative stress factors or to hemodynamic influences on
renal blood flow (McCullough et al., 2011; Hewing et al., 2015;
Lipman et al., 2016). The glomerular filtration rate (GFR)
provides the best index of overall kidney function, whereas serum
creatinine is the most sensitive serum biomarker for detecting
small changes in GFR (Dalton, 2010; Ferguson and Waikar,
2012). Acute kidney injury (AKI) was defined using the AKI
Network (AKIN) criteria (Mehta et al., 2007). Stage 1 AKI was
defined as a 1.5-fold to twofold increase or 0.3 mg/dl increase
in serum creatinine from day 0 to peak creatinine value on
either day 1 or day 2 (McCullough et al., 2011; Kellum et al.,
2013). Other authors relate an acute kidney injury after contrast
medium (CI-AKI) as an absolute increase ≥0.5 mg/dl over
baseline serum creatinine (Maioli et al., 2012). The measurement
of urea concentration, in blood or urine, is another indicator
of kidney function similar to creatinine (Kratz et al., 2002;
McCullough et al., 2011). Urea is the principal nitrogen waste
product of protein metabolism, and it is eliminated from the
body almost exclusively by the kidneys in urine, although serum
creatinine is the main biomarker to define acute kidney injury
(Kellum et al., 2013).
C-reactive protein (CRP) is one of the proteins involved in
physical stress reactions, implicated in renal function acting as a
risk factor for AKI and increasing in AKI (Tang et al., 2018). After
a marathon, the CRP serum concentrations start to rise within
8 h after exercise and peak at 24 h after due to the inflammatory
response caused by tissue injury. In non-elite marathon runners,
CRP increases threefold at 24 h post-race, with this increase
being even greater (40-fold) in ultraendurance races (Kim et al.,
2009). CRP is considered as a biomarker of inflammation in AKI,
impairing tubular regeneration and promoting fibrosis of injured
renal tissue (Tang et al., 2018).
A strenuous, untrained exercise can damage muscle fibers,
increasing membrane permeability and sarcomere degeneration.
As a consequence, at 24 h post-race, large amounts of muscle
proteins will be released into the bloodstream, like creatinine
kinase (CK) (Brancaccio et al., 2007, 2010; Shin et al., 2016),
which is easily assessed in the serum and is a sensitive, but not
specific, marker of muscle tissue damage. Exertional (exercise-
induced) rhabdomyolysis (ER) is well described in athletes
and is the general term for muscle breakdown associated with
strenuous exercise. In endurance exercise, there is no consensus
about the CK level threshold, although healthy population
CK values >15,000 U/L are predictive of renal impairment
(Rawson et al., 2017). In marathon races, CK can increase
threefold at 24 h post-race (Kim et al., 2009) without showing
a correlation between AKI and muscle breakdown (Mansour
et al., 2017). This is due to the fact that the marathon effort
does not involve eccentric contractions, and rhabdomyolysis
is also less common (Scalco et al., 2016). In ultra-endurance
races, CK can increase 35-fold (Kim et al., 2009). Indeed after
a 161-km ultramarathon, a CK of greater than 100,000 U/L has
been frequently observed without apparent health consequences
(Hoffman et al., 2012). Military recruits (Kenney et al., 2012) in
basic training (n = 499) reported mean CK values of 734, 1,226,
and 667 U/L on days 3, 7, and 14 post-exercise, respectively,
and a maximum of 35,056 U/L; however, nobody developed
clinical exertional rhabdomyolysis. The authors suggested that
an increase of CK values by 50-fold above the normal limit
can be a specific marker for exertional rhabdomyolysis in
military recruits.
The bioelectrical impedance vector analysis (BIVA) (Piccoli
et al., 1994) is a method to classify soft tissue mass and hydration
based on patterns of direct bioimpedance measurements.
Bioimpedance (Z) is measured in a whole-body configuration
(standard bioimpedance measurement) (Foster and Lukaski,
1996) at 50 kHz using phase-sensitive devices. The components of
the bioimpedance vector—resistance (R) and reactance (Xc)—are
normalized by the height (H) of the subjects (R/H and Xc/H) and
are represented in the resistance–reactance graph (RXc-graph).
The vector measured on an individual is compared against
the normal intervals of the reference population, expressed in
percentiles of 50, 75, and 95% of normal (Gaussian) distribution
in a bivariate, probabilistic plot (Morrison, 1967). The RXc-
graph method allows (1) the evaluation of an individual vector:
the displacements parallel to the major axis of tolerance ellipses
indicating progressive changes of fluids, whereas displacements
parallel to the minor axis are associated to variations of
cell population density contained in soft tissues and different
trajectories indicate combined changes in both fluid and soft
tissue mass; (2) the evaluation of bioimpedance follow-up, by
the trajectory of successive measurements of the impedance
vector; and (3) the evaluation of groups of subjects using the
bivariate 95% confidence ellipses of the mean vectors. Two
mean vectors, from two independent groups of subjects, can be
compared with the two-sample Hotelling’s T2 test (Hotelling,
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1931). A mean vector displacement in one group of subjects
can be evaluated with the paired one-sample Hotelling’s T2
test (Piccoli and Pastori, 2002). The main advantage of BIVA
is that it does not require any assumption of soft tissue
hydration (normal or abnormal) and body composition and is
independent of body weight. The assessment of soft tissue is done
through direct phase-sensitive bioimpedance measurement—
without requiring the use of prediction equations, avoiding
imprecision of individual estimations (> 10% variability)
associated with regression equations (Piccoli et al., 1994;
Lukaski et al., 2019). In addition, severe dehydration can
occur before the appearance of clinical signs; however, these
can be assessed by combining measurements of phase angle
(PA) and Z vector length from phase-sensitive bioimpedance
devices operating at 50 kHz and plotted on the RXc-graph
(Lukaski et al., 2019).
The major clinical applications of BIVA are focused on kidney
failure to adjust the ultrafiltration sessions (Piccoli, 1998, 2004;
Pillon et al., 2004), to relate edema with mortality (Piccoli
et al., 1996; Nescolarde et al., 2004; Piccoli, 2004; Bouchard
et al., 2009), and more recently (Maioli et al., 2018) as a
valid predictor of CI-AKI. The applications of BIVA method
on endurance events are focused on relating fluid loss after a
bout of exercise-induced dehydration with a lengthening of the
impedance vector along the major axis of the tolerance ellipse
compared to pre-trial measurements (Gatterer et al., 2014) and,
with body mass changes concomitant with training and intensity
of the exercise, finding a significant decrease in body mass and
an increase in bioimpedance variables (Carrasco-Marginet et al.,
2017; Giorgi et al., 2018).
Although previous studies have examined the effect of
endurance exercise in the displacement of the bioimpedance
vector, none of them has examined the relationship between
the serum biomarkers of kidney function with bioimpedance
measurements using BIVA. This study investigates, for the
first time, the relationship between whole-body bioimpedance
vector displacement by BIVA, using a 50-kHz phase-sensitive
bioimpedance analyzer, with renal function through serum




Two months before the 2017 Barcelona Marathon, 23 Caucasian
non-elite runners were voluntarily recruited through the event’s
organizing committee; four of them did not finish the marathon
and thus did not complete the study. The participants who
were under 18 years or over 50 years, along with those of
known chronic pathology, were excluded. The sample size of
19 males (41 ± 4 years old; 77.4 ± 7.1 kg; 1.80 ± 0.1 m;
24.0 ± 2.1 kg/m2) ran 2.7 ± 1.6 h/training per week and had
a running history of 8.2 ± 5.1 years, on average, prior to the
race. All of them were weighed, only with running pants on, 2 h
before the race, immediately after completing the race, and at 48 h
after the race using the same scale (Jata 565, Barcelona, Spain).
Core temperature was measured using a tympanic thermometer
(Braun ThermoScan 7—IRT6520).
The Barcelona Marathon 2017 (42.195 km on asphalt at sea
level) began at 8:30 h at a temperature of 11–14◦C and 68–
79% humidity. During the race, the runners were provided
with guidelines to maintain adequate levels of hydration by
eating and drinking at aid stations every 5 km, with such
sustenance as mineral water, sports drinks, fruits, and nuts. The
first liquid intake was programmed at 60 min into the race:
400 ml for lighter/slower runners and 800 ml for heavier/faster
runners, drinking 100–150 ml every 15–20 min. Commercialized
beverages were provided to runners with an average of 480 mg/l
for Na+, 85 mg/l for K+, and 45 mg/l for Mg2+. The race
time recorded of each participant was the official time from the
race organization.
Ethics approval was obtained from the Hospital Universitari
Germans Trias i Pujol (ICOR-2017-04, REF.CEI, PI-17-037)
according to the principles of the Helsinki Declaration for
experiments with human beings. All the participants gave signed
informed consent.
Clinical Data
Data on serum and urine biomarkers of kidney function
(serum creatinine, urea, serum sodium, and urine test strip),
inflammation (C-reactive protein), and muscle damage (creatine
kinase) were collected 24 h pre-race, immediately post-race, and
at 48 h post-race.
Fasting blood samples (3 × 10 ml) were obtained from
the antecubital vein in EDTA vacutainers at 24 h pre-race,
immediately post-race, and at 48 h post-race. The blood samples
were centrifuged at 3,000 rpm at 4◦C for 10 min in a bench-
top centrifuge. The supernatant serum was aliquoted and stored
on dry ice until all samples were frozen at −80◦C in sealed
Eppendorf tubes to avoid evaporation. Serum urea, creatinine,
CRP, CK, and Na+ were determined using an AU-5800 Chemistry
Analyzer (Beckman Coulter Inc., CA, United States). Serum
osmolality was determined with an Advanced Micro-Osmometer,
Model 3300 (Advanced Instruments Inc., MA, United States)
using freezing point depression. Urine tests were measured with
AUTION MAX AX-4030 (ARKRAY Inc., MN, United States)
analyzer with Uriflet S 9UB strips.
Whole-Body Bioimpedance
Measurements
Tetra-polar bioimpedance measurements were taken at 24 h pre-
race, immediately post-race, and at 48 h post-race according to
the protocol of the standard distal BIA configuration, known
as whole-body (Foster and Lukaski, 1996), with the participant
in supine decubitus. Four adhesive contact electrodes Ag/AgCl
(COVIDIEN Ref. 31050522, COVIDIEN LLC, Mansfield, IL,
United States)—two for injection of current (I) and two for
detecting voltage (V)—were dorsally placed on the right hand in
the third metacarpo-phalangeal articulation and in the carpus,
respectively, 5 cm apart. The pair on the foot was located in
the third metatarso-phalangeal and in the articulation, 6 cm
apart (Figure 1).
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FIGURE 1 | The standard distal BIA configuration electrode placement.
The measurements were obtained at 50 kHz with a phase-
sensitive bioimpedance analyzer (BIA-101 Anniversary; AKERN-
Srl, Florence, Italy), which injected a constant, sinusoidal
alternating current of 245 µARMS. The measurement or
technical errors of the system, determined with a parallel circuit
of precision resistor and capacitor, were <1  for R and <2%
for capacitance.
The supporting staff used a towel to remove dirt and sweat
before the electrode application. The measurement was done
15 min immediately post-race, with a core temperature at around
36◦C. Inside the sanitary facility, the temperature was 21–24.5◦C
and the humidity was 36–38%.
Statistical Analysis
Data were collected at 24 h pre-race, immediately post-race, and
at 48 h post-race, considering the values taken at 24 h pre-
race as baseline. The normality of distribution of the variables
was checked by the Shapiro–Wilk test and the homogeneity of
variances by Levene’s test.
Repeated-measures ANOVA test was used to determine the
effect of the marathon on variables measured at 24 h pre-race,
immediately post-race, and at 48 h post-race using the multiple-
comparison Bonferroni tests. Friedman test was used for repeated
measure of data non-normally distributed with the Wilcoxon test.
In addition, the samples were separated in two groups
according to the cutoff of ≥1.2 mg/dl of serum creatinine
post-race (G1, serum creatinine post-race <1.2 mg/dl and G2,
serum creatinine post-race ≥1.2 mg/dl) considering normal
values of 0.6–1.2 mg/dl by the Clinical Laboratory of the
Hospital Universitari Germans Trias i Pujol (AU-5800 Chemistry
Analyzer (Beckman Coulter Inc; California, United States).
Creatinine clearance rate (CCr or CrCl) is a useful measure
for approximating the GFR (Stevens and Levey, 2009). It
was calculated according to the Cockcroft–Gault equation
(Cockcroft and Gault, 1976) and taking into account that CCr
<60 ml/min/1.73 m2 precedes the onset of kidney failure (Kdigo.,
2013). Mann–Whitney’s U test and Student’s t-test were applied
to analyze non-parametric and parametric variables, respectively.
The variables normally distributed are shown as mean ± SD,
while the non-normally distributed data are shown as median
and interquartile range (IQR). The level of statistical significance




version 24.0 (Armonk, NY: IBM Corp., United States) was used
for data analysis.
Bioelectrical Impedance Vector Analysis
In this study, the individual bioimpedance vectors of runners
[normalized by the runner’s height (H) R/H, Xc/H, and PA]
measured at 24 h pre-race, immediately post-race, and at 48 h
post-race were plotted on the tolerance ellipses (RXc-graph) of
the Caucasian ethnicity adult population (Piccoli et al., 1995) by
using the BIVA software (Piccoli and Pastori, 2002).
The differences in the mean bioimpedance vectors obtained
at 24 h pre-race and immediately post-race were plotted with
their 95% confidence on the dRXc-graph. The paired one-
sample Hotelling’s T2 test (Hotelling, 1931), a multivariate
extension of Student’s t-test for paired data, was used to compare
the differences of the mean bioimpedance vectors. If a 95%
confidence ellipse of a vector displacement covers the null
vector (i.e., abscissa 0, ordinate 0), the vector displacement is
not statistically significant (P < 0.05) at a paired one-sample
Hotelling’s T2 test.
The two-sample Hotelling’s T2 test, a multivariate extension
of Student’s t-test for unpaired data, was used to compare
the mean vectors from two groups (G1 and G2) according to
the cutoff of ≥1.2 mg/dl serum creatinine value immediately
post-race. If the 95% confidence intervals of group mean
do not overlap, the group means are significantly different
(P < 0.05), but the reverse is not necessarily true. Hotelling’s
T2 test is more sensitive than Student’s t-test performed on each
variable and entails a smaller risk of erroneously rejecting the
null hypothesis.
The sample size was estimated for independent groups
according to R/H (n = 6 and 3 by group) and Xc/H (n = 14
and 7 by group) value to have a power (β = 0.80) to detect
an effect size of 0.996, with a 0.05 significance level using
MedCalc statistical software version 19.0.3 (MedCalc Software
bvba, Ostend, Belgium).
In addition, the area under the receiver operating
characteristic (ROC) curve was used to measure the
discriminative capacity of R/H, Xc/H, and PA immediately
post-race and at 48 h post-race in a clinical situation of
AKI stage 1 according to the cutoff of ≥1.2 mg/dl of serum
creatinine post-race.
RESULTS
Table 1 shows the mean ± SD values of body weight, body mass
index (BMI), race time, and percentage change of body weight
as well as the result of the statistical analysis. A decrease of
body weight is related to a negative percentage change of body
weight, while an increment of body weight is related to a positive
percentage change with respect to the baseline values.
The repeated-measures ANOVA test showed statistical
significance (P < 0.01) for both body weight and BMI.
The multiple-comparison Bonferroni tests showed significant
differences (P < 0.01) immediately post-race compared to
24 h pre-race and immediately post-race compared to 48 h
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TABLE 1 | Anthropometric and training data of 19 non-elite marathon runners.


























Difference Weight (%)2−1 −3.2 ± 1.5 – – – – –
Difference Weight (%)3−1 – 0.5 ± 1.3 – – – –
Race time (hh:mm:ss) 3:33:00 ± 0:24:16
aRepeated measures ANOVA test; bBonferroni test. BMI, body mass index.
post-race for body weight and BMI values. However, no statistical
significance (P > 0.05) was found between values in body
weight and BMI at 24 h pre-race and at 48 h post-race. Among
the runners, 63.2% recovered their body weight baseline values
at 48 h post-race.
Clinical Data and BIVA at 24 h Pre-race,
Immediately Post-race, and at 48 h
Post-race
Table 2 shows the clinical data measured at 24 h pre-race,
immediately post-race, and at 48 h post-race as mean ± SD
for normally distributed variables and as median (IQR) for
non-normally distributed data. In addition, also presented are
the results of repeated-measures ANOVA test using multiple-
comparison Bonferroni tests and of Friedman test with Wilcoxon
test for data which were non-normally distributed.
A repeated test showed statistical significance (P < 0.01) in
serum creatinine, serum urea, serum sodium, C-reactive protein,
and creatine kinase.
The serum urea post-race values increased significantly
(P < 0.01) compared to baseline, and 10 of 19 runners (53%)
were above 43 mg/dl. Serum creatinine increased significantly
post-race compared to baseline (P < 0.01), and 12 of 19 runners
(63%) had values over the cutoff of ≥1.2 mg/dl. The CRP at 48 h
post-race increased significantly (P < 0.01) compared to baseline,
and 13 of 19 runners (68%) showed values above 5.0 mg/L (5.2–
15.5 mg/L), with an increase of more than 800% of their baseline
values. The CK at 48 h post-race increased significantly (P< 0.01)
compared to baseline, and 18 of 19 runners (95%) showed values
above 215 U/L (256–1,882 U/L), with an increase from 70 to
1,500% of their baseline values. Any CK values at 48 h post-race
were greater than 2,000 U/L.
The sodium serum levels also increased significantly
immediately post-race with respect to baseline (P < 0.01), but
within normal reference values; however, only two of 19 runners
(10%) had sodium serum levels above 145 mmol/L post-race.
The osmolality serum levels also increased significantly
immediately post-race with respect to baseline (P < 0.01),
but within normal reference values (285–295 mmol/kg),
TABLE 2 | Serum and urine biomarkers of 19 non-elite marathon runners.

















































































Hematuria 0 1 case 0 – – – –
Proteinuria 0 5 cases 0 – – – –
aRepeated measures ANOVA test; bBonferroni test; cFriedman test with Chi-square; dWilcoxon test. CRP, C-reactive protein; CK, creatine kinase.
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TABLE 3 | Whole-body bioimpedance measurements of 19 non-elite marathon runners.




































r 0.69 0.79 0.62 – – – –
aRepeated measures ANOVA test; bBonferroni test. R/H, resistance/height; Xc/H, reactance/height; PA, phase angle.
except in four of 19 runners (21%) who had levels above
295 mmol/kg post-race.
Regarding the urine test, there were some cases of hematuria
(one of 19 runners, 5%) and proteinuria (five of 19 runners, 25%)
found only after the race.
Table 3 shows the values of R/H, Xc/H, and PA described as
mean ± SD, the Pearson’s correlation coefficient, r, between R/H
and Xc/H, and the result of repeated-measures ANOVA test using
multiple-comparison Bonferroni tests.
A repeated ANOVA test showed high statistical significance
(P < 0.01) in R/H and Xc/H as well as PA. Using multiple-
comparison Bonferroni tests, Xc/H showed significant differences
(P < 0.01) immediately post-race compared to values at 24 h pre-
race and at 48 h post-race compared to values at 24 h pre-race.
In addition, Xc/H showed significant differences (P < 0.01) at
48 h post-race compared to immediately post-race. However, R/H
and PA only showed significant differences immediately post-race
compared to values at 24 h pre-race (P < 0.05) and at 48 h post-
race compared to the values immediately post-race (P < 0.01).
Any significant differences were found in R/H and PA at 48 h
post-race compared to values at 24 h pre-race (P > 0.05).
Using the BIVA software (Piccoli and Pastori, 2002), Figure 2
shows the individual bioimpedance vectors at time points 24 h
pre-race, immediately post-race, and 48 h post-race for 19 non-
elite marathon runners compared with the tolerance ellipses for
healthy Caucasian adults (Piccoli et al., 1995) on RXc-graph. Two
runners (runner_11 and runner_17) had a vector displacement
immediately post-race outside of the 50% tolerance ellipse for
healthy Caucasian adults; however, this reverted to 50% tolerance
ellipse at 48 h post-race. Thus, all vector positions were within
the range of normal values. Two other runners (runner_14 and
runner_15) had a vector displacement at 48 h post-race outside
of the inferior pole of the 50% tolerance ellipse for healthy
Caucasian adults, indicating an expansion on extracellular water
and inflammation.
Figure 3A shows the mean bioimpedance vector. The
vector displacement and lengthening along the major axis was
significant compared to baseline but did not cross through
the 75% area of tolerance ellipses of the reference population.
The paired graph (Figure 3B) shows the 95% confidence
ellipse corresponding to the mean of the difference obtained
immediately post-race compared to the vector (baseline) at
24 h pre-race and at 48 h post-race compared to the baseline
vector using the BIVA software (Piccoli and Pastori, 2002).
The 95% confidence ellipse did not cover the null vector
(i.e., dZ/H = 0.0), indicating a statistically significant vector
displacement (P < 0.05) at a paired one-sample Hotelling’s T2
test (Hotelling, 1931).
Clinical Data and BIVA According to the
Cutoff of ≥ 1.2 mg/dl of Serum
Creatinine Immediately Post-race
Table 4 shows the results of anthropometric and clinical data
according to a cutoff of ≥ 1.2 mg/dl of serum creatinine
level immediately post-race for G1 (< 1.2 mg/dl of serum
creatinine level) and G2 (≥1.2 mg/dl of serum creatinine
level) as mean ± SD for normally distributed variables and as
median (IQR) for non-normally distributed data. In addition,
also presented are the statistical results of Mann–Whitney’s
U test or Student’s t-test for non-parametric and parametric
variables, respectively.
According to the cutoff of ≥ 1.2 mg/dl serum creatinine,
63% of the runners (12 of 19) corresponding to G2 showed an
increment of serum creatinine post-race and 58% of them (seven
of 12) showed an increment in serum urea post-race of above
43 mg/dl (cutoff value of serum urea). Serum creatinine reached
values of AKI stage 1, showing increases of≥ 0.3 mg/dl in 83% of
the runners (10 of 12) and increases of ≥ 0.5 mg/dl in 42% of the
runners (five of 12).
The CCr post-race showed a significant decrease (P < 0.01)
upon comparing G1 and G2, although none of the runners (G1
and G2) showed CCr values below 60 ml/min/1.73m2. The CK
at 48 h post-race showed a significant increase (P < 0.05) upon
comparing G1 and G2. All G2 runners had CK values over
215 U/L (282–1,882 U/L). The C-reactive protein at 48 h post-
race showed a significant increase (P < 0.01) upon comparing
G1 and G2. It should be noted that in G2 there are the only
cases of hematuria (8%) and proteinuria (42%) among all the
runners analyzed. Regarding serum urea, serum sodium, and
serum osmolality, no significant differences were seen between
the groups (P > 0.05).
According to the cutoff of ≥ 1.2 mg/dl serum creatinine, no
significant differences were observed in weight loss immediately
post-race (P > 0.05). G1 showed a weight loss immediately from
1.6 to 4.1% and likewise for G2 from 1.9 to 5.0%. However,
significant differences were observed in both body weight and
BMI (P < 0.05).
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FIGURE 2 | Continued
Table 5 shows the values of R/H, Xc/H, and PA immediately
post-race and at 48 h post-race, described as mean ± SD of G1
and G2. In addition, also presented are the Pearson’s correlation
coefficient, r (R/H, Xc/H), and the statistical significance of
Student’s t-test for two independent samples.
No statistical significance was found in whole-body
bioimpedance measurements immediately post-race upon
comparing G1 vs. G2. However, a high statistical significance
(P < 0.01) was found in Xc/H at 48 h post-race, with a tendency
to be statistically significant in R/H and PA.
Figure 4A shows an overlapping of 95% confidence ellipses
between G1 and G2 immediately post-race according to the cutoff
of ≥ 1.2 mg/dl serum creatinine level immediately post-race.
BIVA method with Hotelling’s T2 test shows no significant
differences (T2 = 3.87, F = 1.82, P > 0.05). However, Figure 4B
shows separated 95% confidence ellipses between G1 and G2
at 48 h post-race according to the cutoff of ≥ 1.2 mg/dl
serum creatinine level immediately post-race. Through BIVA
method with Hotelling’s T2 test, the mean groups are significantly
different (T2 = 18.54, F = 8.73, P < 0.05).
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FIGURE 2 | Individual vectors on RXc-graph for 19 non-elite marathon runners 24 h pre-race (1), immediately post-race (2), and 48 h post-race (3); compared to the
tolerance ellipses (50%, 75% and 95% percentiles) of the reference population.
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FIGURE 3 | Mean bioimpedance vectors (A) 24 h pre-race, immediately post-race, and 48 h post-race on RXc-graph and paired graph (B) for 19 non-elite
marathon runners. The paired graph shows the 95% confidence ellipse corresponding to the mean bioimpedance vector difference obtained immediately post-race
and 48 h post-race compared to baseline (24 h pre-race).
According to Figure 2, the runners that belong to the group
G2 are runner_1, runner_2, runner_5, runner_6, runner_7,
runner_10, runner_11, runner_14, runner_15, runner_16,
runner_18, and runner_19.
Figure 5 shows the area under the ROC curve of R/H, Xc/H,
and PA at 48 h post-race in the clinical situation of AKI stage 1
according to the cutoff of≥ 1.2 mg/dl serum creatinine post-race.
TABLE 4 | Anthropometric and clinical data of 19 non-elite marathon runners




G1, n = 7
(<1.2 mg/dL)
G2, n = 12
(≥1.2 mg/dL)
P value
Weight (kg) 70.6 ± 5.7 77.5 ± 6.5 0.035
Weight-lost (%) −2.83± 1.28 −3.44± 1.55 0.397
BMI (kgm−2) 22.0 ± 1.7 23.9 ± 1.9 0.047
Serum Urea (mg/dL) 40.9 ± 9.2 44.4 ± 9.2 0.429
Serum Creatinine (mg/dL) 1.07 ± 0.07 1.39 ± 0.15 0.000
Increment Serum Creatinine
(mg/dL)
0.17 ± 0.04 0.40 ± 0.16 0.000
CCr (mL/min) 93.2 ± 10.1 76.4 ± 9.6 0.002










Serum Sodium (mmol/L) 142.0 ± 2.2 141.5 ± 3.4 0.730
Osmolality (mmol/kg) 290.1 ± 5.0 294.3 ± 7.1 0.286
Hematuria 0 cases 1 case –
Proteinuria 0 cases 5 cases –
§48h post-race values. BMI, body mass index; CCr, creatinine clearance rate; CRP,
C-reactive protein; CK, creatine kinase.
According to AKI stage 1, the Xc/H at 48 h post-race variable
shows a high significant difference (P = 0.003), with area below
the ROC curve of 0.917 and a standard error of 0.067.
DISCUSSION
This study analyzes the relationship between whole-body
bioimpedance vector displacement, by BIVA, and renal function
through serum and urine biomarkers, after a marathon, in non-
elite marathon runners.
Transient significant increases of urea and creatinine,
indicating renal dysfunction, have been described in runners after
completion of the marathon (Kratz et al., 2002; McCullough
et al., 2011). A repeated-measures test showed high statistical
significance (P < 0.01) in serum creatinine, urea, serum sodium,
CRP, and CK. Using multiple-comparison tests, serum creatinine
showed statistical significance (P < 0.01) immediately post-
race and at 48 h post-race with respect to the values at 24 h
pre-race and at 48 h post-race with respect to the values
immediately post-race. The inflammation biomarker CRP and
the muscle damage biomarker CK showed significantly different
values (P < 0.01) at 48 h post-race compared to baseline values
according to its rate of production, with concentration peaks
at 48 h. The mean bioimpedance vector showed a lengthening
along the major axis, with a migration above (left) the minor
axis of the tolerance ellipse, immediately post-race compared to
baseline, relating to the fluid loss and muscle activation during
a marathon. A 50-kHz, phase-sensitive BIA analyzer yields
passive bioelectrical measurements of bioimpedance module (Z)
and its components R (which is the opposition to the flow of
an alternating current through intra- and extra-cellular ionic
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TABLE 5 | Whole-body bioimpedance measurements (R/H, Xc/H, and PA) immediately post-race, 48 h post-race and statistical results between G1 and G2, according
to cut-off of ≥1.2 mg/dL serum creatinine level immediately post-race.












R/H (/m) 292.9 ± 14.4 274.1 ± 6.7 276.4 ± 19.8 259.0 ± 8.3 0.072 0.077
Xc/H (/m) 35.6 ± 2.6 31.9 ± 1.9 33.1 ± 3.9 28.2 ± 2.4 0.151 0.003
PA (◦) 6.94 ± 0.41 6.64 ± 0.40 6.82 ± 0.49 6.23 ± 0.44 0.609 0.065
r 0.60 0.52 0.65 0.59 – –
2 Immediately post-race G1 vs. G2; 348 h post-race G1 vs. G2. R/H, resistance/height; Xc/H, reactance/height; PA, phase angle.
FIGURE 4 | 95% confidence ellipse for both groups immediately post-race (A) and 48 h post-race (B) separated according to cut-off of ≥1.2 mg/dL of serum
creatinine level immediately post-race.
solutions) and Xc (which indicates the capacitive component
of tissue interfaces and cell membranes). The parameter Xc is
associated with the integrity of the soft tissue structures and R
with the hydration state of the soft tissue. The phase angle (PA),
calculated as the arc tangent of Xc/R, allows the non-invasive
assessment of intra- to extracellular fluid (Lukaski et al., 2019).
Changes in bioimpedance variables are indicators of fluid (R)
and cell structure integrity (Xc and PA). Muscle contraction can
be described based on two variables, length and tension, which
imply a major delay between I and V and, as consequence, major
Xc and PA post-race.
The paired graph (mean of the difference post-race compared
to the baseline vector) did not cover the null vector (i.e.,
dZ/H = 0.0), indicating a statistically significant vector
displacement (P < 0.05) at a paired one-sample Hotelling’s
T2 test. Although the mean differences at 48 h post-race
compared to the baseline vector did not cover the null vector,
there is a tendency to cover it (recovering the pre-race values).
Several factors induce transient changes on renal filtration
function, such as hemodynamic influences on renal blood
flow, neurohormonal, inflammatory, or oxidative stress factors
(McCullough et al., 2011). In the current study, the subjects who
developed AKI stage 1 (G2) had more CK and more CRP at 48 h
post-race than the group which did not develop AKI stage 1. G2
showed an increase of CK at 48 h post-race by threefold to 16-
fold above the reference values measured at 24 h pre-race, while
G1 showed an increase of one- to sixfold above the reference
values. Although no runners presented CK over 1,890 U/L at
48 h post-race (ninefold above the normal reference values), not
close to exertional (exercise-induced) rhabdomyolysis (Kenney
et al., 2012), we believe that the inflammation situation that
occurs, together with other factors that may be intra-renal or
thermal hemodynamic, may be the cause of the kidney damage
(Mansour et al., 2017). Although it is not known which renal
structure is damaged, there are data that suggest that the tubule
may be damaged (Mansour et al., 2017). The alterations in the
urinary sediment and the urinalysis observed (hematuria and
proteinuria) are less described and also certify the involvement
of renal parenchyma. To date, an increased risk of chronic renal
failure in marathoners has not been described, but we cannot
deny that repeated kidney damage may have long-term negative
effects. AKI stage 1 showed a significant Spearman correlation
with CRP values at 48 h post-race (r = 0.767, P = 0.000)
and with CCr immediately post-race (r = −0.869, P = 0.000).
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FIGURE 5 | ROC Curve of R/H, Xc/H, and PA 48 h post-race according to
cut-off of ≥1.2 mg/dL of serum creatinine post-race.
However, AKI stage 1 shows no correlation with CK at 48 h
post-race (r = 0.376, P = 0.113). Exertional rhabdomyolysis
can be a complication presenting as asymptomatic physiologic
elevations of creatine kinase after exercise, leading to acute
kidney injury (Szczepanik et al., 2014), but none of the non-
elite runners analyzed presented with rhabdomyolysis. This
could indicate that due to the fact that marathon does not
involve eccentric contractions, rhabdomyolysis is less common
(Clarkson, 2007).
Previous studies have related the effects of endurance exercise
to serum C-reactive protein and inflammatory markers (Kasapis
and Thompson, 2005). All runners analyzed had increases in
CRP of 190–7,200% at 48 h after the race compared to the
reference levels, showing that global inflammation may be related
to the inflammation of the nephron (correlated with a significant
increase of creatinine levels).
On the other hand, G2 showed a significant increase (P< 0.05)
in CRP values at 48 h post-race (290–7000%) compared to
baseline (24 h pre-race). Among G2 runners, 92% showed very
high levels of CRP values over the cutoff (> 5 mg/L), which is
associated with an independent predictor of AKI (Tang et al.,
2018), and 83% of them showed high increase levels of creatinine
(≥ 0.3 mg/dl), which is associated with AKI stage 1 (McCullough
et al., 2011). Thus, the transient reduction in renal filtration
function is more related to inflammatory factors (CRP, P < 0.01)
than to muscle damage (CK, P < 0.05).
According to the cutoff of ≥ 1.2 mg/dl serum creatinine, no
significant differences were observed in weight loss immediately
after the race (P > 0.05) between G1 and G2. After a marathon,
body weight loss is at around 2–3% (Sawka et al., 2007; Thomas
et al., 2016) and at 5–6% after ultra-endurance events without
clinical implications (Tam and Noakes, 2013). G1 showed a
weight loss of 2–4% and G2 of 2–5% without renal implications.
According to the cutoff of ≥ 1.2 mg/dl serum creatinine post-
race, neither has there been significant differences (P > 0.05)
between G1 and G2 in terms of serum osmolality post-race
values used to evaluate the hemoconcentration influences on
renal blood flow.
By BIVA, the 95% of confidence ellipses at 48 h post-
race showed significant differences (T2 = 18.54, F = 8.73,
P < 0.05) between runners with serum creatinine levels post-race
of ≥ 1.2 mg/dl (G2) compared to those with serum creatinine
levels < 1.2 mg/dl (G1). This significant difference is mainly due
to the parameter Xc/H (P < 0.01), which showed a decrease in
G2 at 48 h post-race with respect to values at 24 h pre-race from
-3.3 to -12.4% and in G1 from 0 to -3.1%. According to the BIVA
method (Piccoli et al., 1994), this decrease is due to the expansion
of extracellular water (fluid overload) and inflammation. The
Xc/H at 48 h post-race showed a significant Spearman rho
correlation with CRP at 48 h post-race (r = −0.467, P = 0.044).
AKI stage 1 showed a significant Pearson correlation with Xc/H
at 48 h post-race (r = − 0.710, P = 0.001) and phase-angle (PA)
at 48 h post-race (r = − 0.586, P = 0.008). In addition, among
R/H, Xc/H, and PA at 48 h post-race, the variable with major
area under ROC curve was Xc/H 48h post-race (AUC = 0.917).
The runners with serum creatinine levels post-race ≥ 1.2 mg/dl
(G2) showed Xc/H at 48 h post-race values ≤ 30.5 , with 85.7%
sensitivity and 91.7% specificity.
The major limitation of this study is the small sample size
and the fact that only the male gender was analyzed. When
performing the BIVA method, the male and the female samples
cannot be processed together because of the reference values
(R and Xc) of the healthy population which change according
to gender (male and female) and age range (childhood and
adults). For this reason, we found the tolerance ellipses (50, 75,
and 95%) of the reference population to beseparated by gender
(Piccoli et al., 1995). However, the strength of this study is the
use of a non-invasive method (BIVA) to assess renal function
and muscle damage.
CONCLUSION
The transient reduction in renal filtration function is more related
to the inflammatory factors rather than to muscle damage. In
all the runners observed, serum creatinine and urea values at
48 h post-race compared to baseline values were recovered.
There is a direct relationship between a marathon race in non-
elite runners and the serum biomarkers of kidney function and
inflammation, with a high percentage of AKI stage 1. The runners
with AKI stage 1 presented greater CRP values at 48 h post-
race, which is associated with systemic inflammation. Phase-
sensitive measurements at 50 kHz with BIVA could be a non-
invasive method to assess kidney function in runners through
the Xc/H value at 48 h post-race, with a decrease of > 3%
with respect to the baseline value. It would be necessary to
study several consecutive marathon races, adding 24 h post-race
measurements, on runners who frequently suffer transient AKI
stage 1, including female runners, to determine the long-term
negative effects on renal function.
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